Blocking IL1 Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-14-0969
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Lidamycin Inhibits Tumor Growth and Pulmonary Metastasis in Murine Breast Carcinoma and Shows Synergy With Paclitaxel

Chinese Science Bulletin
2013English

Interleukin-10 Ablation Promotes Tumor Development, Growth, and Metastasis

Cancer Research
Cancer ResearchOncology
2011English

SPOCK1 Promotes Tumor Growth and Metastasis in Human Prostate Cancer

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2016English

Blocking CXCR4-Mediated Cyclic AMP Suppression Inhibits Brain Tumor Growth in Vivo

Cancer Research
Cancer ResearchOncology
2007English

Nef-M1, a CXCR4 Peptide Antagonist, Enhances Apoptosis and Inhibits Primary Tumor Growth and Metastasis in Breast Cancer

Journal of Cancer Therapy
2013English

Blocking of Cytokines Signalling Attenuates Evoked and Spontaneous Neuropathic Pain Behaviours in the Paclitaxel Rat Model of Chemotherapy-Induced Neuropathy

European Journal of Pain
MedicineAnesthesiologyPain Medicine
2017English

Low-Dose Paclitaxel Inhibits Tumor Cell Growth by Regulating Glutaminolysis in Colorectal Carcinoma Cells

Frontiers in Pharmacology
Pharmacology
2017English

Corrigendum: DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway

Frontiers in Pharmacology
Pharmacology
2020English

NLRP3 Promotes Tumor Growth and Metastasis in Human Oral Squamous Cell Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy